<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Antenatal depression: Pregnancy and neonatal outcomes</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Antenatal depression: Pregnancy and neonatal outcomes</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Antenatal depression: Pregnancy and neonatal outcomes</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sophie Grigoriadis, MD, MA, PhD, FRCPC</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer Payne, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Charles J Lockwood, MD, MHCM</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Solomon, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 07, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H969786281"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Antenatal maternal depression is associated with adverse effects upon pregnancy and neonatal outcomes [<a href="#rid1">1-3</a>]. In addition, antenatal depression is associated with abnormal infant and child development, as well as cognitive problems and psychopathology in the offspring.</p><p>This topic reviews the association between antenatal depression and pregnancy and neonatal outcomes. The association of antenatal depression with abnormal child development, as well as cognitive impairment and psychopathology in the offspring, is discussed separately, as are the risks of antenatal antidepressants and the clinical features, assessment, diagnosis, and treatment of antenatal depression:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/106322.html" rel="external">"Antenatal depression: Risks of abnormal infant and child development"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/107653.html" rel="external">"Antenatal depression: Risks of cognitive impairment and psychopathology in the offspring"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/89067.html" rel="external">"Antenatal use of antidepressants and the potential risk of teratogenicity and adverse pregnancy outcomes: Selective serotonin reuptake inhibitors"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/100334.html" rel="external">"Antenatal use of antidepressants and risks of teratogenicity and adverse pregnancy outcomes: Drugs other than selective serotonin reuptake inhibitors"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5007.html" rel="external">"Antenatal exposure to selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs): Neonatal outcomes"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1718.html" rel="external">"Unipolar major depression during pregnancy: Epidemiology, clinical features, assessment, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/108261.html" rel="external">"Mild to moderate episodes of antenatal unipolar major depression: Choosing treatment"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1703.html" rel="external">"Severe antenatal unipolar major depression: Choosing treatment"</a>.)</p><p></p><p class="headingAnchor" id="H3929829047"><span class="h1">QUALITY OF EVIDENCE</span><span class="headingEndMark"> — </span>Information about the association between antenatal depression and adverse pregnancy outcomes and adverse outcomes in the offspring comes from low to moderate quality studies. (See  <a class="medical medical_review" href="/z/d/html/106322.html" rel="external">"Antenatal depression: Risks of abnormal infant and child development", section on 'Quality of evidence'</a>.)</p><p class="headingAnchor" id="H1460599426"><span class="h1">POTENTIAL MECHANISMS</span><span class="headingEndMark"> — </span>There are several possible direct and indirect mechanisms by which antenatal maternal depression may adversely affect pregnancy outcomes as well as offspring. (See  <a class="medical medical_review" href="/z/d/html/106322.html" rel="external">"Antenatal depression: Risks of abnormal infant and child development", section on 'Potential mechanisms'</a>.)</p><p class="headingAnchor" id="H2904173737"><span class="h1">PREGNANCY AND NEONATAL OUTCOMES</span><span class="headingEndMark"> — </span>Antenatal depression is associated with an increased risk of multiple poor obstetric outcomes, including spontaneous abortion, bleeding, operative deliveries, and preterm birth [<a href="#rid4">4,5</a>]. However, the observed effects are small.</p><p class="headingAnchor" id="H1860084805"><span class="h2">Teratogenicity</span><span class="headingEndMark"> — </span>It is not clear if antenatal depression is associated with a small risk of teratogenicity, because the studies that have investigated the association between depression and teratogenicity may be confounded by the use of antidepressants and the severity of the depressive syndrome (antidepressants may be more likely to be used during pregnancy for severe depressive episodes than for mild to moderate syndromes):</p><p class="bulletIndent1"><span class="glyph">●</span>A national registry study of women who delivered babies included patients with antenatal major depression (n &gt;4000) and controls without depression (n &gt;500,000) [<a href="#rid6">6</a>]. Major congenital anomalies were more likely in the offspring of depressed mothers than controls (odds ratio 1.4, 95% CI 1.3-1.6).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another registry study of deliveries included women with major depression (n &gt;3000) and women with no mental illness (n &gt;430,000) and found that congenital anomalies were more likely in offspring of depressed women than controls (odds ratio 1.4, 95% CI 1.2-1.6) [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>However, in a nationally representative database of primary care records that included live births of women with depression who were not treated with antidepressants (n &gt;13,000) and women without depression who were not exposed to antidepressants (n &gt;325,000) [<a href="#rid8">8</a>], the prevalence of major congenital anomalies for the two groups was comparable.</p><p></p><p>General information about teratogenicity is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/110900.html" rel="external">"Congenital anomalies: Causes"</a>.)</p><p class="headingAnchor" id="H2050870923"><span class="h2">Pregnancy loss</span><span class="headingEndMark"> — </span>Antenatal depression appears to be associated with a small increased risk of pregnancy loss (spontaneous abortion):</p><p class="bulletIndent1"><span class="glyph">●</span>A registry study identified pregnant women with a diagnosis of depression in the four years before pregnancy (n &gt;7000) and a control group of pregnant women who were not diagnosed with depression (n &gt;19,000); neither group received antidepressants [<a href="#rid9">9</a>]. After controlling for potential confounding factors (eg, maternal age; socioeconomic status; and use of antipsychotics, anticonvulsants, and benzodiazepines in the first trimester), the analyses found that the risk of spontaneous abortion was slightly greater in the women with depression than in the controls (relative risk 1.1, 95% CI 1.0-1.2) [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A national registry study included pregnant women who were diagnosed with depression or anxiety in the year prior to pregnancy (n &gt;3000) and pregnant women who did not receive a diagnosis of depression or anxiety in the prior year (controls; n &gt;1,000,000); neither group used selective serotonin reuptake inhibitors [<a href="#rid10">10</a>]. After controlling for potential confounding factors (eg, maternal age, socioeconomic status, and prior miscarriages), the analyses found that the risk of spontaneous abortion was greater in the depressed/anxious group than in the controls (hazard ratio 1.3, 95% CI 1.1-1.4).</p><p></p><p>General information about pregnancy loss is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5439.html" rel="external">"Pregnancy loss (miscarriage): Terminology, risk factors, and etiology"</a>.)</p><p class="headingAnchor" id="H1338888295"><span class="h2">Late fetal death</span><span class="headingEndMark"> — </span>It is not known whether antenatal depression is associated with late fetal death or stillbirth (delivery of a fetus ≥20 weeks of gestation with no signs of life), due to inconsistent results across retrospective studies:</p><p class="bulletIndent1"><span class="glyph">●</span>A national registry study of women who delivered babies included patients with major depression during pregnancy (n &gt;4000) and controls without depression (n &gt;500,000) [<a href="#rid6">6</a>]. Late fetal death was more likely in depressed mothers than controls (odds ratio 1.8, 95% CI 1.2-2.6).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study of administrative claims data included pregnant women who were depressed (n &gt;5000) or not depressed (n &gt;20,000) [<a href="#rid11">11</a>]. After adjusting for potential confounding factors (eg, age, comorbidity such as chronic hypertension, and medication), the analyses found that late fetal death occurred more often in depressed women than nondepressed women (odds ratio 1.7, 95% CI 1.1-2.6).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>However, another registry study of deliveries included women with major depression (n &gt;3000) and women with no mental illness (n &gt;430,000) and found that the rate of late fetal death was comparable in depressed women and controls (0.4 and 0.5 percent) [<a href="#rid7">7</a>].</p><p></p><p>General information about late fetal death is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6827.html" rel="external">"Stillbirth: Incidence, risk factors, etiology, and prevention"</a>.)</p><p class="headingAnchor" id="H1118949254"><span class="h2">Preeclampsia</span><span class="headingEndMark"> — </span>Most of the evidence suggests that antenatal depression is not associated with preeclampsia (hypertensive disorders of pregnancy) [<a href="#rid12">12</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of four prospective observational studies (sample size not reported) compared pregnant women who were depressed with pregnant women who were not depressed and found that the probability of preeclampsia was comparable for the two groups [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In addition, several studies not included in the meta-analysis have also found that depression was not associated with hypertensive disorders of pregnancy [<a href="#rid7">7,13-15</a>]. As examples:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a registry study that included pregnant women with depression who were not treated with antidepressant drugs (n &gt;65,000) and pregnant women without depression (n &gt;230,000), the prevalence of preeclampsia was 2 percent in both groups [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A retrospective study of an administrative claims database examined pregnant women with depression who were not exposed to antidepressants (nearly 60,000 patients) and women without depression (n &gt;1,000,000); the prevalence of preeclampsia in both groups was 5 percent [<a href="#rid17">17</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A study of administrative claims data included pregnant women who were depressed (n &gt;5000) or not depressed (n &gt;20,000) [<a href="#rid11">11</a>]. After adjusting for potential confounding factors (eg, age, comorbidity such as chronic hypertension, and medication), the analyses found that the frequency of preeclampsia/eclampsia was identical for each group (2 percent).</p><p></p><p>Nevertheless, a meta-analysis of five studies (nearly 4000 pregnant patients) found that the risk of preeclampsia was greater in patients with depression than in nondepressed patients (odds ratio 1.7, 95% CI 1.3-2.1) [<a href="#rid18">18</a>].</p><p>General information about preeclampsia is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6814.html" rel="external">"Preeclampsia: Clinical features and diagnosis"</a>.)</p><p class="headingAnchor" id="H3583320217"><span class="h2">Gestational diabetes</span><span class="headingEndMark"> — </span>Antenatal depression is not associated with gestational diabetes:</p><p class="bulletIndent1"><span class="glyph">●</span>A national registry study of live births found that, among women who were depressed (n &gt;15,000) and women who were not depressed (n &gt;340,000), the prevalence of gestational diabetes was 1 percent in both groups [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another registry study of deliveries included women with major depression (n &gt;3000) and women with no mental illness (n &gt;430,000) and found that gestational diabetes in depressed women and controls was 3.4 and 4.7 percent (statistical significance was not reported) [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study of administrative claims data included pregnant women who were depressed (n &gt;5000) or not depressed (n &gt;20,000) [<a href="#rid11">11</a>]. After adjusting for potential confounding factors (eg, age, comorbidity such as chronic hypertension, and medication), the analyses found that the frequency of gestational diabetes was identical for each group (12 percent).</p><p></p><p>General information about gestational diabetes is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4800.html" rel="external">"Gestational diabetes mellitus: Obstetric issues and management"</a>.)</p><p class="headingAnchor" id="H3969291796"><span class="h2">Placental abruption</span><span class="headingEndMark"> — </span>Antenatal depression is not associated with placental abruption (partial or complete placental detachment prior to delivery of the fetus):</p><p class="bulletIndent1"><span class="glyph">●</span>A national registry study of live births included infants born to women who were depressed (n &gt;15,000) and women who were not depressed (n &gt;340,000); the prevalence of placental abruption was 0.3 percent in both groups [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another registry study of deliveries included women with major depression (n &gt;3000) and women with no mental illness (n &gt;430,000), and found that the frequency of placental abruption in both depressed women and controls was 1 percent [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study of administrative claims data included pregnant women who were depressed (n &gt;5000) or not depressed (n &gt;20,000) [<a href="#rid11">11</a>]. After adjusting for potential confounding factors (eg, age, comorbidity such as chronic hypertension, and medication), the analyses found that the frequency of placental abruption was identical for each group (1 percent).</p><p></p><p>General information about placental abruption is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6826.html" rel="external">"Acute placental abruption: Pathophysiology, clinical features, diagnosis, and consequences"</a>.)</p><p class="headingAnchor" id="H1592280130"><span class="h2">Bleeding</span><span class="headingEndMark"> — </span>It is not clear if antenatal depression is associated with hemorrhage during pregnancy and/or the postpartum period. Two retrospective studies found that antenatal depression was associated with hemorrhage, but the observed effect was clinically small, and a third retrospective found that antenatal depression was not associated with bleeding:</p><p class="bulletIndent1"><span class="glyph">●</span>A national registry study identified pregnant women who were depressed but not treated with antidepressant drugs (n &gt;1000) and pregnant women who were neither depressed nor exposed to antidepressants (n &gt;55,000) [<a href="#rid5">5</a>]. Bleeding occurred in more depressed women than controls during the first trimester (23 versus 20 percent) and the second trimester (12 versus 9 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A national registry study of live births included women with psychiatric diagnoses who were not treated with antidepressants or antipsychotics (n = 9652, 42 percent of whom had a depressive disorder) and women with no psychiatric diagnoses and no exposure to antidepressants or antipsychotics (n &gt;31,000) [<a href="#rid12">12</a>]. In analyses adjusted for potential confounding factors (eg, maternal age, socioeconomic status, and smoking), the likelihood of bleeding during or after delivery was greater in depressed women than in controls (odds ratio 1.3, 95% CI 1.1-1.5).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study of administrative claims data included pregnant women who were depressed (n &gt;5000) or not depressed (n &gt;20,000) [<a href="#rid11">11</a>]. After adjusting for potential confounding factors (eg, age, comorbidity such as chronic hypertension, and medication), the analyses found that the frequency of antepartum hemorrhage was similar for each group (approximately 9.0 percent), as was the frequency of postpartum hemorrhage (approximately 3.5 percent).</p><p></p><p>General information about antenatal and postpartum hemorrhage is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6799.html" rel="external">"Evaluation and differential diagnosis of vaginal bleeding before 20 weeks of gestation"</a> and  <a class="medical medical_review" href="/z/d/html/6710.html" rel="external">"Overview of postpartum hemorrhage"</a>.)</p><p class="headingAnchor" id="H3767942318"><span class="h2">Operative delivery</span><span class="headingEndMark"> — </span>Antenatal depression is often associated with operative deliveries (eg, cesarean delivery or instrumentally assisted delivery) [<a href="#rid12">12,19</a>], but the clinical effect is small. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of seven observational studies (n &gt;4000 pregnant women) found that the risk of operative deliveries was greater in women with depression (relative risk 1.3, 95% CI 1.1-1.5) [<a href="#rid18">18</a>]. However, the observed effect was modest, and heterogeneity across studies was moderate to large.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study of administrative claims data included pregnant women who were depressed (n &gt;5000) or not depressed (n &gt;20,000) [<a href="#rid11">11</a>]. After adjusting for potential confounding factors (eg, age, comorbidity such as chronic hypertension, and medication), the analyses found that cesarean delivery was more likely to occur in depressed women than in nondepressed women (odds ratio 1.25, 95% CI 1.16-1.34). However, the clinical effect was small.</p><p></p><p>General information about cesarean delivery and instrumentally assisted delivery is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4475.html" rel="external">"Cesarean birth: Preoperative planning and patient preparation"</a> and  <a class="medical medical_review" href="/z/d/html/4474.html" rel="external">"Assisted (operative) vaginal birth"</a>.)</p><p class="headingAnchor" id="H625509738"><span class="h2">Preterm birth</span><span class="headingEndMark"> — </span>Numerous studies consistently indicate that antenatal maternal depressive symptoms are associated with preterm birth (&lt;37 weeks of gestation) [<a href="#rid6">6,7,12,14,19-26</a>]. Relatively old studies suggest that the clinical effect is small, whereas more recent studies indicate that the association between antenatal depression and preterm birth is moderately large.</p><p>Evidence that antenatal maternal depression is at least modestly associated with preterm birth includes the following:</p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of 20 prospective observational studies (sample size not reported) found that antenatal maternal depression was associated with preterm birth (relative risk 1.13, 95% CI 1.06-1.21), and the risk was comparable for depressed patients who were treated or not treated with antidepressant medications. However, heterogeneity across the 20 studies was significant [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A second meta-analysis of 15 prospective observational studies (sample size not reported) found that the probability of premature delivery was greater in pregnant women who were depressed than in pregnant women who were not depressed (odds ratio 1.37, 95% CI 1.04-1.81); however, heterogeneity across studies was moderate to large [<a href="#rid1">1</a>]. In addition, a subgroup analysis of six studies that excluded or controlled for patients treated with medications found that depression was not associated with preterm birth.</p><p></p><p>In addition, more recent studies indicate that antenatal depression is moderately associated with preterm birth:</p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of 14 studies examined preterm birth in pregnant women with depression who received neither pharmacotherapy nor psychotherapy (n &gt;3900) and in nondepressed pregnant women (n &gt;17,000) [<a href="#rid28">28</a>]. All of the studies were prospective except one (total n = 66 pregnant women). Antenatal depression was associated with an increased risk of preterm birth, and the clinical effect was moderate (odds ratio 1.6, 95% CI 1.3-1.9).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A subsequent prospective study (n &gt;2000 pregnant women) compared the risk of preterm birth in women with antenatal depression (n = 274) and in nondepressed women (n = 1799) [<a href="#rid29">29</a>]. After adjusting for potential confounding factors (eg, maternal age, marital status, and smoking status), the analyses found that antenatal depression was associated with an increased risk of preterm birth (relative risk 1.6, 95% CI 1.1-2.2).</p><p></p><p>In addition, multiple studies suggest that antenatal depression may be associated with both very preterm birth (&lt;32 weeks of gestation) and moderately preterm birth (32 to 36 weeks of gestation) [<a href="#rid7">7,14,25</a>].</p><p>Depression in expectant fathers may also be associated with an increased risk of preterm birth [<a href="#rid14">14</a>].</p><p>Relatively few studies suggest that antenatal depression is not associated with preterm birth:</p><p class="bulletIndent1"><span class="glyph">●</span>A prospective study compared pregnant women with major depression (n = 222) at less than 17 weeks of gestation and pregnant women without major depression (n = 2432) [<a href="#rid15">15</a>]. After adjusting for potential confounding factors (eg, prepregnancy maternal body mass index [BMI], history of smoking and heavy drinking, and use of serotonin reuptake inhibitors), the analyses found that the risk of preterm birth was comparable for depressed and nondepressed women.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another prospective study compared pregnant women with probable major depression (n = 145) at 19 to 26 weeks of gestation and pregnant women without major depression (n = 636) [<a href="#rid30">30</a>]. After adjusting for potential confounding factors (eg, prepregnancy maternal BMI, history of preterm birth, and smoking status), the analyses found that the risk of preterm birth was comparable for depressed and nondepressed women.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study of administrative claims data included pregnant women who were depressed (n &gt;5000) or not depressed (n &gt;20,000) [<a href="#rid11">11</a>]. After adjusting for potential confounding factors (eg, age, comorbidity such as chronic hypertension, and medication), the analyses found that the frequency of preterm birth was comparable for depressed and nondepressed women (6 and 5 percent).</p><p></p><p>Separate topics discuss general information about preterm birth, including other risk factors. (See  <a class="medical medical_review" href="/z/d/html/6761.html" rel="external">"Spontaneous preterm birth: Overview of risk factors and prognosis"</a>.)</p><p class="headingAnchor" id="H956376112"><span class="h2">Gestational age</span><span class="headingEndMark"> — </span>Prospective observational studies generally suggest that antenatal depression is not associated with gestational age at delivery:</p><p class="bulletIndent1"><span class="glyph">●</span>In a meta-analysis of eight prospective studies (sample size not reported), exposure to antenatal depression was not associated with gestational age [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of seven studies examined gestational age in pregnant women with depression who received neither pharmacotherapy nor psychotherapy (n &gt;2000) and in nondepressed pregnant women (n &gt;10,000) [<a href="#rid28">28</a>]. All of the studies were prospective except one (total n = 66 pregnant women). Antenatal depression was not associated with gestational age.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A prospective study not included in either meta-analysis examined offspring of women with antenatal depression who were not treated with antidepressants (n = 54) and offspring of women who were healthy (n = 62); gestational age in the two groups was comparable [<a href="#rid31">31</a>].</p><p></p><p>However, other studies suggest that antenatal depression is associated with small for gestational age infants (birth weight &lt;10<sup>th</sup> percentile for gestational age). As an example, a prospective study compared pregnant women with probable major depression (n = 145) at 19 to 26 weeks of gestation and pregnant women without major depression (n = 636) [<a href="#rid30">30</a>]. After adjusting for potential confounding factors (eg, prepregnancy maternal weight and height, history of intrauterine growth restriction, and use of antidepressants), the analyses found that the risk of small for gestational age was greater in women with probable major depression (odds ratio 1.82, 95% CI 1.01-3.25).</p><p class="headingAnchor" id="H2296712328"><span class="h2">Fetal growth restriction</span><span class="headingEndMark"> — </span>Most of the evidence suggests that antenatal depression does not increase the risk for fetal (intrauterine) growth restriction [<a href="#rid11">11,12,24,32</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of 12 prospective observational studies (sample size not reported) found that antenatal maternal depression was not associated with intrauterine growth restriction [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A subsequent prospective study enrolled pregnant women (n &gt;2100) during the first trimester and periodically assessed depressive symptoms and performed serial ultrasound examinations throughout pregnancy [<a href="#rid32">32</a>]. Greater depressive symptoms were not associated with altered fetal growth.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A national registry study of live births included infants born to women who were depressed (n &gt;15,000) and women who were not depressed (n &gt;340,000); the prevalence of small for gestational age babies was 2 percent in both groups [<a href="#rid14">14</a>].</p><p></p><p>Nevertheless, several studies suggest that depression during pregnancy may be associated with reduced fetal growth [<a href="#rid6">6,7,22,33</a>]. As an example, a prospective study examined fetal growth with ultrasonography each trimester in depressed pregnant women who were not treated with antidepressants (n = 570) and in a control group of pregnant women with few or no depressive symptoms (n = 7027) [<a href="#rid34">34</a>]. Compared with the control group, fetal weight gain in fetuses of depressed mothers was less by approximately 4.4 g per week.</p><p class="headingAnchor" id="H3555412094"><span class="h2">Low birth weight</span><span class="headingEndMark"> — </span>It is not known if antenatal depression is associated with low birth weight (&lt;2500 g) due to inconsistent results across studies [<a href="#rid19">19,22,25,31,35,36</a>].</p><p>Evidence that supports an association between antenatal depression and low birth weight includes the following [<a href="#rid24">24</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of 11 prospective observational studies (sample size not reported) found that antenatal maternal depression was associated with low birth weight, but the observed effect was small (relative risk 1.2, 95% CI 1.1-1.3) [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A subsequent meta-analysis of eight studies examined low birth weight in pregnant women with depression who received neither pharmacotherapy nor psychotherapy (n &gt;900) and in nondepressed pregnant women (n &gt;2300) [<a href="#rid28">28</a>]. All of the studies were prospective except one (total n = 66 pregnant women). Antenatal depression was associated with an increased risk of low birth weight, and the clinical effect was moderate to large (odds ratio 2.0, 95% CI 1.2-3.1).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A national registry study of women who delivered babies included patients with major depression during pregnancy (n &gt;4000) and controls without depression (n &gt;500,000) [<a href="#rid6">6</a>]. After adjusting for potential confounding factors (eg, maternal age, socioeconomic status, and smoking), the analyses found that low birth weight occurred more often in the offspring of depressed mothers than controls (odds ratio 1.4, 95% CI 1.2-1.6).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A retrospective study of pregnant women (n &gt;17,000) found that depressive syndromes were present in 7 percent [<a href="#rid26">26</a>]. After adjusting for potential confounding factors (eg, maternal age, socioeconomic status, and health problems such as diabetes and hypertension), the analyses found that antenatal depression was associated with an increased risk of low birth weight (odds ratio 1.7, 95% CI 1.2-2.3).</p><p></p><p>However, several studies have found that antenatal depression is not associated with low birth weight:</p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of 10 prospective observational studies (sample size not reported) found that birth weight in the offspring of pregnant women who were depressed and pregnant women who were not depressed was comparable [<a href="#rid1">1</a>]. In addition, the prevalence of low birth weight was comparable in the offspring of pregnant women who were depressed and pregnant women who were not depressed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A subsequent prospective study not included in either meta-analysis enrolled pregnant women with depressive symptoms (n = 152) and nondepressed pregnant women (n = 539) [<a href="#rid37">37</a>]. After controlling for potential confounds (eg, prepregnancy BMI, alcohol use during pregnancy, and gestational age), the risk of low birth weight in the two groups was comparable.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study of administrative claims data included pregnant women who were depressed (n &gt;5000) or not depressed (n &gt;20,000); the two groups were matched for age, pregnancy year, and parity [<a href="#rid11">11</a>]. The frequency of low birth weight was similar for each group (approximately 2.5 percent).</p><p></p><p class="headingAnchor" id="H2396467477"><span class="h2">Neonatal intensive care unit admission</span><span class="headingEndMark"> — </span>The best evidence suggests that maternal antenatal depression is not associated with an increased risk of admission to a neonatal intensive care unit (NICU) [<a href="#rid21">21</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>In a meta-analysis of five prospective observational studies (sample size not reported), NICU admissions were comparable for the offspring of women who were depressed and the offspring of women who were not depressed [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A subsequent meta-analysis of two prospective studies examined NICU admissions for offspring of pregnant women with depression who received neither pharmacotherapy nor psychotherapy (n = 54) and offspring of nondepressed pregnant women (n = 146) [<a href="#rid28">28</a>]. Antenatal depression was not associated with an increased risk of NICU admission.</p><p></p><p class="headingAnchor" id="H1881747003"><span class="h2">Breastfeeding</span><span class="headingEndMark"> — </span>Antenatal depression may increase the risk of not breastfeeding one's infant, but the effect generally appears to be small:</p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of four prospective observational studies (sample size not reported) found that the probability of breastfeeding was lower in postnatal women who were depressed during pregnancy than in women who were not depressed (odds ratio 0.7, 95% CI 0.6-0.8) [<a href="#rid1">1</a>]. However, the meta-analysis did not exclude patients using antidepressants or control for use of antidepressants; thus, it is possible that depressed women were less likely to breastfeed because they were taking antidepressant medications.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A subsequent prospective study of pregnant women (n = 145) found that antenatal depression was associated with a decreased probability of either initiating exclusive breastfeeding or breastfeeding exclusively for at least three months (odds ratio 0.86, 95% CI 0.76-0.99) [<a href="#rid38">38</a>].</p><p></p><p>In addition, a retrospective study of pregnant women (n &gt;17,000, including 7 percent with depressive syndromes) found that antenatal depression was not associated with nonexclusive breastfeeding in the early postnatal period [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H1586335334"><span class="h1">EFFECT OF TREATMENT</span><span class="headingEndMark"> — </span>Beyond the known benefits of antidepressant treatment in the general population, more research is needed to understand the effect of successful treatment for antenatal depression upon pregnancy outcomes [<a href="#rid39">39</a>]. However, antenatal depression may perhaps cause adverse pregnancy and neonatal outcomes through the biological consequences of depression (eg, dysregulation of the hypothalamic-pituitary-adrenal axis) acting upon the fetus [<a href="#rid40">40</a>]. To the extent that this is true, it is possible that treating antenatal depression may prevent the adverse outcomes.</p><p>Evidence supporting the hypothesis that treating antenatal depression may avert adverse pregnancy outcomes includes a small retrospective study that compared outcomes in the offspring of women with antenatal major depression who were treated with selective serotonin reuptake inhibitors (SSRIs; n = 23), women with antenatal major depression who were not treated with SSRIs (n = 36), and women without depression who were not exposed to SSRIs (n = 30) [<a href="#rid41">41</a>]. Gestational age and birth weight were each lower in the newborns of depressed women who were not treated, compared with the control infants and the infants of depressed women who were treated. By contrast, outcomes for the controls and the infants exposed in utero to SSRIs were comparable. However, the meaning of these results is not clear because many studies suggest that antenatal depression is not associated with gestational age or low birth weight. (See <a class="local">'Gestational age'</a> above and <a class="local">'Low birth weight'</a> above.)</p><p class="headingAnchor" id="H1230510767"><span class="h1">ABNORMAL INFANT AND CHILD DEVELOPMENT</span><span class="headingEndMark"> — </span>Antenatal depression may be associated with abnormal infant and child development. (See  <a class="medical medical_review" href="/z/d/html/106322.html" rel="external">"Antenatal depression: Risks of abnormal infant and child development"</a>.)</p><p class="headingAnchor" id="H4189763177"><span class="h1">COGNITIVE PROBLEMS AND PSYCHOPATHOLOGY</span><span class="headingEndMark"> — </span>Antenatal depression may be associated with cognitive problems and psychopathology in the offspring. (See  <a class="medical medical_review" href="/z/d/html/107653.html" rel="external">"Antenatal depression: Risks of cognitive impairment and psychopathology in the offspring"</a>.)</p><p class="headingAnchor" id="H4084696246"><span class="h1">TREATING ANTENATAL DEPRESSION</span><span class="headingEndMark"> — </span>Several options are available for treating antenatal depression. (See  <a class="medical medical_review" href="/z/d/html/108261.html" rel="external">"Mild to moderate episodes of antenatal unipolar major depression: Choosing treatment"</a> and  <a class="medical medical_review" href="/z/d/html/1703.html" rel="external">"Severe antenatal unipolar major depression: Choosing treatment"</a>.)</p><p class="headingAnchor" id="H1193572762"><span class="h1">RISKS OF ANTIDEPRESSANTS</span><span class="headingEndMark"> — </span>The risks of antenatal antidepressants with regard to fetal and infant/child development are discussed separately. </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/100334.html" rel="external">"Antenatal use of antidepressants and risks of teratogenicity and adverse pregnancy outcomes: Drugs other than selective serotonin reuptake inhibitors"</a> and  <a class="medical medical_review" href="/z/d/html/5007.html" rel="external">"Antenatal exposure to selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs): Neonatal outcomes"</a> and  <a class="medical medical_review" href="/z/d/html/89067.html" rel="external">"Antenatal use of antidepressants and the potential risk of teratogenicity and adverse pregnancy outcomes: Selective serotonin reuptake inhibitors"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/100334.html" rel="external">"Antenatal use of antidepressants and risks of teratogenicity and adverse pregnancy outcomes: Drugs other than selective serotonin reuptake inhibitors"</a> and  <a class="medical medical_review" href="/z/d/html/5007.html" rel="external">"Antenatal exposure to selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs): Neonatal outcomes"</a> and  <a class="medical medical_review" href="/z/d/html/89067.html" rel="external">"Antenatal use of antidepressants and the potential risk of teratogenicity and adverse pregnancy outcomes: Selective serotonin reuptake inhibitors"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/100334.html" rel="external">"Antenatal use of antidepressants and risks of teratogenicity and adverse pregnancy outcomes: Drugs other than selective serotonin reuptake inhibitors"</a> and  <a class="medical medical_review" href="/z/d/html/5007.html" rel="external">"Antenatal exposure to selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs): Neonatal outcomes"</a> and  <a class="medical medical_review" href="/z/d/html/89067.html" rel="external">"Antenatal use of antidepressants and the potential risk of teratogenicity and adverse pregnancy outcomes: Selective serotonin reuptake inhibitors"</a>.)</p><p></p><p class="headingAnchor" id="H2335629878"><span class="h1">POSTPARTUM DEPRESSION</span><span class="headingEndMark"> — </span>Antenatal depression is a risk factor for postpartum depression, which in turn is associated with abnormal child development as well as cognitive problems and psychopathology in the child. (See  <a class="medical medical_review" href="/z/d/html/107664.html" rel="external">"Postpartum depression: Adverse consequences in mothers and their children"</a>.)</p><p class="headingAnchor" id="H1490979865"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/15342.html" rel="external">"Patient education: Depression in adults (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/4868.html" rel="external">"Patient education: Depression in adults (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H3557798020"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Information about the association between antenatal depression and adverse pregnancy outcomes and adverse outcomes in the offspring comes from low to moderate quality studies. (See  <a class="medical medical_review" href="/z/d/html/106322.html" rel="external">"Antenatal depression: Risks of abnormal infant and child development", section on 'Quality of evidence'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antenatal depression is associated with an increased risk of multiple adverse obstetric and neonatal outcomes, including pregnancy loss, operative deliveries, preterm birth, and not breastfeeding one's infant. However, the observed effects are typically small. (See <a class="local">'Pregnancy loss'</a> above and <a class="local">'Operative delivery'</a> above and <a class="local">'Preterm birth'</a> above and <a class="local">'Breastfeeding'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It is not clear whether antenatal depression is associated with teratogenicity, late fetal death, antenatal or postpartum hemorrhage, or low birth weight. (See <a class="local">'Teratogenicity'</a> above and <a class="local">'Late fetal death'</a> above and <a class="local">'Bleeding'</a> above and <a class="local">'Low birth weight'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most of the evidence suggests that antenatal depression is not associated with preeclampsia, gestational diabetes, placental abruption, gestational age, fetal growth restriction, and admission to a neonatal intensive care unit. (See <a class="local">'Preeclampsia'</a> above and <a class="local">'Gestational diabetes'</a> above and <a class="local">'Placental abruption'</a> above and <a class="local">'Gestational age'</a> above and <a class="local">'Fetal growth restriction'</a> above and <a class="local">'Neonatal intensive care unit admission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antenatal depression may be associated with abnormal infant and child development, as well as cognitive problems and psychopathology in the offspring. (See  <a class="medical medical_review" href="/z/d/html/106322.html" rel="external">"Antenatal depression: Risks of abnormal infant and child development"</a> and  <a class="medical medical_review" href="/z/d/html/107653.html" rel="external">"Antenatal depression: Risks of cognitive impairment and psychopathology in the offspring"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Several options are available for treating antenatal depression. (See  <a class="medical medical_review" href="/z/d/html/108261.html" rel="external">"Mild to moderate episodes of antenatal unipolar major depression: Choosing treatment"</a> and  <a class="medical medical_review" href="/z/d/html/1703.html" rel="external">"Severe antenatal unipolar major depression: Choosing treatment"</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Grigoriadis S, VonderPorten EH, Mamisashvili L, et al. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry 2013; 74:e321.</a></li><li><a class="nounderline abstract_t">Pearlstein T. Depression during Pregnancy. Best Pract Res Clin Obstet Gynaecol 2015; 29:754.</a></li><li class="breakAll">National Institute for Health and Care Excellence (NICE). Antenatal and postnatal mental health: clinical management and service guidance. NICE clinical guideline 192. December 2014. http://www.nice.org.uk/guidance/cg192 (Accessed on January 28, 2016).</li><li><a class="nounderline abstract_t">Chaudron LH. Complex challenges in treating depression during pregnancy. Am J Psychiatry 2013; 170:12.</a></li><li><a class="nounderline abstract_t">Lupattelli A, Spigset O, Koren G, Nordeng H. Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol 2014; 34:143.</a></li><li><a class="nounderline abstract_t">Räisänen S, Lehto SM, Nielsen HS, et al. Risk factors for and perinatal outcomes of major depression during pregnancy: a population-based analysis during 2002-2010 in Finland. BMJ Open 2014; 4:e004883.</a></li><li><a class="nounderline abstract_t">Mei-Dan E, Ray JG, Vigod SN. Perinatal outcomes among women with bipolar disorder: a population-based cohort study. Am J Obstet Gynecol 2015; 212:367.e1.</a></li><li><a class="nounderline abstract_t">Ban L, Gibson JE, West J, et al. Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study. BJOG 2014; 121:1471.</a></li><li><a class="nounderline abstract_t">Almeida ND, Basso O, Abrahamowicz M, et al. Risk of Miscarriage in Women Receiving Antidepressants in Early Pregnancy, Correcting for Induced Abortions. Epidemiology 2016; 27:538.</a></li><li><a class="nounderline abstract_t">Johansen RL, Mortensen LH, Andersen AM, et al. Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage - assessing potential biases. Paediatr Perinat Epidemiol 2015; 29:72.</a></li><li><a class="nounderline abstract_t">Huang HC, Sung FC, Chen PC, et al. Obstetric outcomes in pregnant women with and without depression: population-based comparison. Sci Rep 2017; 7:13937.</a></li><li><a class="nounderline abstract_t">Malm H, Sourander A, Gissler M, et al. Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data. Am J Psychiatry 2015; 172:1224.</a></li><li><a class="nounderline abstract_t">Avalos LA, Chen H, Li DK. Antidepressant medication use, depression, and the risk of preeclampsia. CNS Spectr 2015; 20:39.</a></li><li><a class="nounderline abstract_t">Liu C, Cnattingius S, Bergström M, et al. Prenatal parental depression and preterm birth: a national cohort study. BJOG 2016; 123:1973.</a></li><li><a class="nounderline abstract_t">Yonkers KA, Gilstad-Hayden K, Forray A, Lipkind HS. Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes. JAMA Psychiatry 2017; 74:1145.</a></li><li><a class="nounderline abstract_t">Palmsten K, Setoguchi S, Margulis AV, et al. Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants? Am J Epidemiol 2012; 175:988.</a></li><li><a class="nounderline abstract_t">Palmsten K, Huybrechts KF, Michels KB, et al. Antidepressant use and risk for preeclampsia. Epidemiology 2013; 24:682.</a></li><li><a class="nounderline abstract_t">Hu R, Li Y, Zhang Z, Yan W. Antenatal depressive symptoms and the risk of preeclampsia or operative deliveries: a meta-analysis. PLoS One 2015; 10:e0119018.</a></li><li><a class="nounderline abstract_t">Oberlander TF, Warburton W, Misri S, et al. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006; 63:898.</a></li><li><a class="nounderline abstract_t">Engelstad HJ, Roghair RD, Calarge CA, et al. Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy. Neonatology 2014; 105:149.</a></li><li><a class="nounderline abstract_t">Stein A, Pearson RM, Goodman SH, et al. Effects of perinatal mental disorders on the fetus and child. Lancet 2014; 384:1800.</a></li><li><a class="nounderline abstract_t">Szegda K, Markenson G, Bertone-Johnson ER, Chasan-Taber L. Depression during pregnancy: a risk factor for adverse neonatal outcomes? A critical review of the literature. J Matern Fetal Neonatal Med 2014; 27:960.</a></li><li><a class="nounderline abstract_t">Nordeng H, van Gelder MM, Spigset O, et al. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol 2012; 32:186.</a></li><li><a class="nounderline abstract_t">Kim DR, Sockol LE, Sammel MD, et al. Elevated risk of adverse obstetric outcomes in pregnant women with depression. Arch Womens Ment Health 2013; 16:475.</a></li><li><a class="nounderline abstract_t">Venkatesh KK, Riley L, Castro VM, et al. Association of Antenatal Depression Symptoms and Antidepressant Treatment With Preterm Birth. Obstet Gynecol 2016; 127:926.</a></li><li><a class="nounderline abstract_t">Eastwood J, Ogbo FA, Hendry A, et al. The Impact of Antenatal Depression on Perinatal Outcomes in Australian Women. PLoS One 2017; 12:e0169907.</a></li><li><a class="nounderline abstract_t">Grote NK, Bridge JA, Gavin AR, et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010; 67:1012.</a></li><li><a class="nounderline abstract_t">Jarde A, Morais M, Kingston D, et al. Neonatal Outcomes in Women With Untreated Antenatal Depression Compared With Women Without Depression: A Systematic Review and Meta-analysis. JAMA Psychiatry 2016; 73:826.</a></li><li><a class="nounderline abstract_t">Ncube CN, Enquobahrie DA, Gavin AR. Racial Differences in the Association Between Maternal Antenatal Depression and Preterm Birth Risk: A Prospective Cohort Study. J Womens Health (Larchmt) 2017; 26:1312.</a></li><li><a class="nounderline abstract_t">Szegda K, Bertone-Johnson ER, Pekow P, et al. Depression During Pregnancy and Adverse Birth Outcomes Among Predominantly Puerto Rican Women. Matern Child Health J 2017; 21:942.</a></li><li><a class="nounderline abstract_t">Nulman I, Koren G, Rovet J, et al. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry 2012; 169:1165.</a></li><li><a class="nounderline abstract_t">Grobman WA, Wing DA, Albert P, et al. Maternal Depressive Symptoms, Perceived Stress, and Fetal Growth. J Ultrasound Med 2017; 36:1639.</a></li><li><a class="nounderline abstract_t">Goedhart G, Snijders AC, Hesselink AE, et al. Maternal depressive symptoms in relation to perinatal mortality and morbidity: results from a large multiethnic cohort study. Psychosom Med 2010; 72:769.</a></li><li><a class="nounderline abstract_t">El Marroun H, Jaddoe VW, Hudziak JJ, et al. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry 2012; 69:706.</a></li><li><a class="nounderline abstract_t">Accortt EE, Cheadle AC, Dunkel Schetter C. Prenatal depression and adverse birth outcomes: an updated systematic review. Matern Child Health J 2015; 19:1306.</a></li><li><a class="nounderline abstract_t">Gentile S. Untreated depression during pregnancy: Short- and long-term effects in offspring. A systematic review. Neuroscience 2017; 342:154.</a></li><li><a class="nounderline abstract_t">Chang HY, Keyes KM, Lee KS, et al. Prenatal maternal depression is associated with low birth weight through shorter gestational age in term infants in Korea. Early Hum Dev 2014; 90:15.</a></li><li><a class="nounderline abstract_t">Figueiredo B, Canário C, Field T. Breastfeeding is negatively affected by prenatal depression and reduces postpartum depression. Psychol Med 2014; 44:927.</a></li><li><a class="nounderline abstract_t">Jarde A, Morais M, Kingston D, et al. Does non-pharmacological therapy for antenatal depression reduce risks for the infant? Arch Womens Ment Health 2016; 19:549.</a></li><li><a class="nounderline abstract_t">Pearson RM, Evans J, Kounali D, et al. Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years. JAMA Psychiatry 2013; 70:1312.</a></li><li><a class="nounderline abstract_t">Şahingöz M, Yuksel G, Karsidag C, et al. Birth weight and preterm birth in babies of pregnant women with major depression in relation to treatment with antidepressants. J Clin Psychopharmacol 2014; 34:226.</a></li></ol></div><div id="topicVersionRevision">Topic 107638 Version 9.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23656857" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25976080" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Depression during Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25976080" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Depression during Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23288385" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Complex challenges in treating depression during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24135843" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25398675" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Risk factors for and perinatal outcomes of major depression during pregnancy: a population-based analysis during 2002-2010 in Finland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25446660" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Perinatal outcomes among women with bipolar disorder: a population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24612301" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27031036" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Risk of Miscarriage in Women Receiving Antidepressants in Early Pregnancy, Correcting for Induced Abortions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25382157" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage - assessing potential biases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29066809" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Obstetric outcomes in pregnant women with and without depression: population-based comparison.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26238606" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25778691" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Antidepressant medication use, depression, and the risk of preeclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26786413" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Prenatal parental depression and preterm birth: a national cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28903165" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22442287" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23873072" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Antidepressant use and risk for preeclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25789626" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Antenatal depressive symptoms and the risk of preeclampsia or operative deliveries: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16894066" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24356332" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25455250" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Effects of perinatal mental disorders on the fetus and child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24044422" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Depression during pregnancy: a risk factor for adverse neonatal outcomes? A critical review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22367660" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23934018" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Elevated risk of adverse obstetric outcomes in pregnant women with depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27054941" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Association of Antenatal Depression Symptoms and Antidepressant Treatment With Preterm Birth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28095461" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The Impact of Antenatal Depression on Perinatal Outcomes in Australian Women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20921117" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27276520" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Neonatal Outcomes in Women With Untreated Antenatal Depression Compared With Women Without Depression: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28622475" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Racial Differences in the Association Between Maternal Antenatal Depression and Preterm Birth Risk: A Prospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27995411" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Depression During Pregnancy and Adverse Birth Outcomes Among Predominantly Puerto Rican Women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23128923" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28393386" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Maternal Depressive Symptoms, Perceived Stress, and Fetal Growth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20668282" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Maternal depressive symptoms in relation to perinatal mortality and morbidity: results from a large multiethnic cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22393202" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25452215" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Prenatal depression and adverse birth outcomes: an updated systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26343292" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Untreated depression during pregnancy: Short- and long-term effects in offspring. A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24331828" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Prenatal maternal depression is associated with low birth weight through shorter gestational age in term infants in Korea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23822932" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Breastfeeding is negatively affected by prenatal depression and reduces postpartum depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26395260" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Does non-pharmacological therapy for antenatal depression reduce risks for the infant?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24108418" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24525643" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Birth weight and preterm birth in babies of pregnant women with major depression in relation to treatment with antidepressants.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
